{"id":"ati-502","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL4594441","moleculeType":"Small molecule","molecularWeight":"395.39"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking the 5-HT2A receptor, ATI-502 is thought to reduce excessive neural activity associated with various neurological disorders.","oneSentence":"ATI-502 is a small molecule inhibitor of the serotonin receptor 5-HT2A.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:21:53.667Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of essential tremor"}]},"trialDetails":[{"nctId":"NCT03759340","phase":"PHASE2","title":"ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)","status":"TERMINATED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2019-01-15","conditions":"Alopecia Areata, Alopecia Universalis, Alopecia Totalis","enrollment":56},{"nctId":"NCT03585296","phase":"PHASE2","title":"A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis","status":"COMPLETED","sponsor":"Aclaris Therapeutics, Inc.","startDate":"2018-07-10","conditions":"Atopic Dermatitis","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ATI-502","genericName":"ATI-502","companyName":"Aclaris Therapeutics, Inc.","companyId":"aclaris-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ATI-502 is a small molecule inhibitor of the serotonin receptor 5-HT2A. Used for Treatment of essential tremor.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}